Literature DB >> 15630905

Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients.

M Numata1, M Nakayama, T Hosoya, C M Hoff, C J Holmes, M Schalling, L Nordfors, B Lindholm.   

Abstract

Encapsulating peritoneal sclerosis (EPS) is a serious complication of PD. The cause(s) of EPS are unknown but may include peritonitis and long duration of PD treatment. However, EPS may also develop in some patients without a history of peritonitis or with rather short duration of PD therapy. It has been suggested that an increasing peritoneal solute transport rate (PSTR) as a function of time on PD treatment is a risk factor for EPS development after transfer to hemodialysis, and that high PSTR is associated with an increased peritoneal microvessels surface area. Other putative mechanisms might include advanced glycated end products (AGE) and their receptors, RAGE. The purpose of this study was to investigate genetic variations in PD patients developing EPS in comparison to PD patients without EPS. SNPs in genes related to angiogenesis as well as RAGE were analyzed. Twenty patients (M/F: 12/8, mean age at start of PD 42.2 years, mean duration of PD 8.4 years) who were diagnosed as EPS during the period 1982 - 2002 at Jikei University Hospital and a matched control group (n = 20) of nonEPS PD patients were studied. The following 5 SNPs were analyzed: VEGF 936 C/T, ecNOS -786 T/C, 298 Glu/Asp, and RAGE -374 T/A, and -429 T/C. The SNPs were analyzed by the pyrosequencing method. The C allele (T/C and C/C) in the RAGE -429T/C genotype was not found in any of the EPS patients (EPS, T/T: 20/20 (100%), nonEPS, T/T: 15/20 (75%), T/C: 4/20 (20%), C/C: 1/2 0(5%), nonC allele vs C allele, p = 0.013), although every allele was found in other SNPs. We conclude that these preliminary data show that whereas genotypes directly related to angiogenesis did not differ between EPS and nonEPS patients, it is noteworthy that no patients in the EPS group had a C allele in the RAGE -429T/C genotype. This might indicate a possible genetic contribution to the development of EPS that is related to RAGE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15630905     DOI: 10.5414/cnp62455

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  8 in total

Review 1.  Genetic Polymorphisms and Peritoneal Membrane Function.

Authors:  Imad Siddique; K Scott Brimble; Louise Walkin; Angela Summers; Paul Brenchley; Sarah Herrick; Peter J Margetts
Journal:  Perit Dial Int       Date:  2014-11-13       Impact factor: 1.756

Review 2.  Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions.

Authors:  Anneleen Pletinck; Raymond Vanholder; Nic Veys; Wim Van Biesen
Journal:  Nat Rev Nephrol       Date:  2012-07-10       Impact factor: 28.314

3.  Pentraxin 3 as a new biomarker of peritoneal injury in peritoneal dialysis patients.

Authors:  Reo Kanda; Chieko Hamada; Kayo Kaneko; Takanori Nakano; Keiichi Wakabayashi; Hiroaki Io; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  J Artif Organs       Date:  2012-09-27       Impact factor: 1.731

4.  Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.

Authors:  Ryo Yamamoto; Yasushi Otsuka; Masaaki Nakayama; Yukio Maruyama; Naohiko Katoh; Masato Ikeda; Hiroyasu Yamamoto; Keitaro Yokoyama; Yoshindo Kawaguchi; Masato Matsushima
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

5.  Suppression of peritoneal thickening by histamine in a mouse model of peritoneal scraping.

Authors:  Keyue Liu; Toshihiro Yorozuya; Naoto Adachi; Atsuko Motoki; Kanji Ninomiya; Hisao Mabuchi; Noriyuki Iwamoto; Masahiro Nishibori
Journal:  Clin Exp Nephrol       Date:  2014-09-06       Impact factor: 2.801

Review 6.  Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis.

Authors:  Andreas Fusshoeller
Journal:  Pediatr Nephrol       Date:  2007-07-19       Impact factor: 3.714

7.  Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?

Authors:  Jesús Loureiro; Guadalupe Gónzalez-Mateo; José Jimenez-Heffernan; Rafael Selgas; Manuel López-Cabrera; Abelardo Aguilera Peralta
Journal:  Int J Nephrol       Date:  2013-02-10

Review 8.  Opportunities and Challenges for Genetic Studies of End-Stage Renal Disease in Canada.

Authors:  Vinusha Kalatharan; Mathieu Lemaire; Matthew B Lanktree
Journal:  Can J Kidney Health Dis       Date:  2018-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.